Citius Pharmaceuticals, Inc. Notes Payable
Citius Pharmaceuticals, Inc. (CTXR) had Notes Payable of $172.97 thousand as of 2021-06-30, per its 10-K filed 2022-12-22.
Discontinued › Balance Sheet › Liabilities › Notes Payable
us-gaap:NotesPayable · last filed 2022-12-22
- 2021-06-30: Notes Payable $172.97K.
- 2016-03-31: Notes Payable $772.97K.
| Period end | Notes Payable |
|---|---|
| 2021-06-30 | $172.97K 10-K · filed 2022-12-22 |
| 2016-03-31 | $772.97K 10-Q · filed 2016-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |